Anti-Amitryptiline Antibody (19201)
Anti-Amitryptiline Antibody (19201) (19201-GRP)
Products
Description
Amitriptyline is used to treat a number of mental illnesses including major depressive disorder and anxiety disorder, and less commonly attention deficit hyperactivity disorder and bipolar disorder. Other uses include prevention of migraines, treatment of neuropathic pain such as fibromyalgia and postherpetic neuralgia and less commonly insomnia. Amitriptyline was discovered in 1960 and approved by the FDA in 1961. It is on the WHO Model List of Essential Medicines.
Specifications
| Manufacturer Cat# | 19201 |
|---|---|
| Concentration | Lot Specific |
| Formulation | This monoclonal antibody is formulated in phosphate buffered saline (PBS) pH 7.2 - 7.4 with no carrier protein or preservatives added. |
| Clone | AM10-106.9 |
| Target | Amitriptyline |
| Applications | ELISA |
| Storage | This antibody is stable for at least one (1) year at -20°C to -70°C. Store product in appropriate aliquots to avoid multiple freeze-thaw cycles. |
| Protein | Amitriptyline |